Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome

J Alzheimers Dis. 2008 Apr;13(3):295-302. doi: 10.3233/jad-2008-13307.

Abstract

Virtually all individuals with Down syndrome (DS) develop neurofibrillary tangles, a characteristic brain lesion of Alzheimer's disease (AD), when they reach the fourth decade of life. In AD, neurofibrillary tangles are thought to result from abnormal hyperphosphorylation of tau protein, which, in turn, can result from down-regulation of protein phosphatase (PP) 2A, a major brain tau phosphatase. The abnormal hyperphosphorylation of tau in DS had not yet been characterized, and its causes were not understood. In this study, by using quantitative Western blot analysis, we found that the level of the catalytic subunit of PP2A, but not of PP1, PP2B or PP5, was dramatically decreased. The decrease of PP2A level correlated negatively to tau level and tau phosphorylation at several abnormal hyperphosphorylation sites, including Ser199, Thr205, Thr212, Ser262, Ser396 and Ser422. Our results indicate that PP2A is down-regulated in DS brain and suggest that this down-regulation might be involved in the abnormal hyperphosphorylation and accumulation of tau.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Blotting, Western
  • Brain / metabolism
  • Brain / pathology
  • Down Syndrome / metabolism*
  • Down Syndrome / pathology
  • Down-Regulation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurofibrillary Tangles / metabolism
  • Neurofibrillary Tangles / pathology
  • Phosphorylation
  • Protein Phosphatase 2 / metabolism*
  • Temporal Lobe / pathology
  • tau Proteins / metabolism*

Substances

  • MAPT protein, human
  • tau Proteins
  • Protein Phosphatase 2